Literature DB >> 6427411

Regional distribution of prostaglandins D2, E2, and F2 alpha and related enzymes in postmortem human brain.

T Ogorochi, S Narumiya, N Mizuno, K Yamashita, H Miyazaki, O Hayaishi.   

Abstract

The presence of prostaglandins D2, E2, and F2 alpha was demonstrated and their contents measured in various regions of postmortem human brain, pineal body, and pituitary by using specific radioimmunoassays and gas chromatography-mass spectrometry. The three prostaglandins were widely distributed in similar concentrations ranging from several hundred pg/g wet weight to about 40 ng/g wet weight. Prostaglandins D2 and E2 showed consistent and similar regional distributions in all six brains tested; amounts were high in pineal body, pituitary, olfactory bulb, and hypothalamus. On the other hand, prostaglandin F2 alpha was distributed more evenly. Prostaglandin D synthetase and prostaglandin E synthetase activities were found in cerebrum homogenate from a single subject and were recovered from the 100,000 X g supernatant. The presence of 1 mM glutathione, reduced form, markedly stimulated the activity of prostaglandin E synthetase, but did not affect prostaglandin D synthetase activity. Activity of 15-hydroxyprostaglandin dehydrogenase was found in the cerebrum homogenate and was partially purified. This enzyme required NADP as a cofactor and copurified with prostaglandin E 9-ketoreductase.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6427411     DOI: 10.1111/j.1471-4159.1984.tb06680.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  35 in total

1.  Prostaglandin D2 DP1 receptor is beneficial in ischemic stroke and in acute exicitotoxicity in young and old mice.

Authors:  Abdullah Shafique Ahmad; Muzamil Ahmad; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Age (Dordr)       Date:  2010-03-05

2.  Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2.

Authors:  T V Petrova; K T Akama; L J Van Eldik
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

3.  Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice.

Authors:  N Eguchi; T Minami; N Shirafuji; Y Kanaoka; T Tanaka; A Nagata; N Yoshida; Y Urade; S Ito; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

4.  Kindling-induced learning deficiency and possible cellular and molecular involved mechanisms.

Authors:  Mohammad Amin Sherafat; Abdolaziz Ronaghi; Leila Ahmad-Molaei; Mohammad Nejadhoseynian; Rasoul Ghasemi; Arman Hosseini; Nima Naderi; Fereshteh Motamedi
Journal:  Neurol Sci       Date:  2012-06-29       Impact factor: 3.307

Review 5.  Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain.

Authors:  Kenneth I Strauss
Journal:  Brain Behav Immun       Date:  2007-11-08       Impact factor: 7.217

6.  The formation of prostaglandins in the postmortem cerebral cortex of Alzheimer-type dementia patients.

Authors:  N Iwamoto; K Kobayashi; K Kosaka
Journal:  J Neurol       Date:  1989-02       Impact factor: 4.849

7.  Subchronic infusion of the product of inflammation prostaglandin J2 models sporadic Parkinson's disease in mice.

Authors:  Sha-Ron Pierre; Marijke A M Lemmens; Maria E Figueiredo-Pereira
Journal:  J Neuroinflammation       Date:  2009-07-25       Impact factor: 8.322

8.  Effect of prostaglandin D2 on the femoral bone mineral density in ovariectomized rats.

Authors:  T Takagi; T Yamamoto; S Asano; H Tamaki
Journal:  Calcif Tissue Int       Date:  1993-06       Impact factor: 4.333

9.  Human brain prostaglandin D synthase has been evolutionarily differentiated from lipophilic-ligand carrier proteins.

Authors:  A Nagata; Y Suzuki; M Igarashi; N Eguchi; H Toh; Y Urade; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

Review 10.  Prostaglandin J2: a potential target for halting inflammation-induced neurodegeneration.

Authors:  Maria E Figueiredo-Pereira; Chuhyon Corwin; John Babich
Journal:  Ann N Y Acad Sci       Date:  2016-01-08       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.